Characterizing the molecular signatures induced by oncolytic measles virus along with conventional therapies in experimental glioma

DSpace Repository


Dateien:
Aufrufstatistik

URI: http://hdl.handle.net/10900/85880
http://nbn-resolving.de/urn:nbn:de:bsz:21-dspace-858804
http://dx.doi.org/10.15496/publikation-27269
Dokumentart: Dissertation
Date: 2020-12-18
Language: English
Faculty: 4 Medizinische Fakultät
Department: Medizin
Advisor: Tabatabai, Ghazaleh (Prof. Dr. Dr.)
Day of Oral Examination: 2018-12-18
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Keywords: Gliom , Masern , Synergie
Other Keywords:
Glioma
oncolytic measles virus
synergy
License: Publishing license excluding print on demand
Show full item record

Inhaltszusammenfassung:

Dissertation ist gesperrt bis 18. Dezember 2020 !

Abstract:

Scientific Objectives 1. To determine the feasibility of oncolytic virotherapy using MeV in glioblastoma through characterization of glioma cell lines and primary glioblastoma cell cultures in vitro. 2. To identify a synergistic combination of MeV with SOC, radiotherapy and alkylating chemotherapy in glioma cell lines (LN229 and LNZ308), glioma stem-like cells (GS8) and temozolomide-resistant LN229 cells (R-LN229) in vitro. 3. To characterize and validate the molecular mechanisms of synergy in the combinatorial treatment regimen through transcriptome analysis using RNA sequencing. 4. To delineate the treatment-induced immunological profile of MeV-infected glioma cells established through presentation of antigens using HLA ligandome analysis.

This item appears in the following Collection(s)